We will have limited operations from 15:00 Wednesday 24 December 2025 (AEDT) until Friday 2 January 2026. Find out how to contact us during the holiday period.
Sponsor content
110 result(s) found, displaying 31 to 40
-
Cancellation by sponsorRequested by Mayne Pharma International Pty Ltd
-
Cancellation by sponsorRequested by Mayne Pharma International Pty Ltd
-
Cancellation by sponsorRequested by Mayne Pharma International Pty Ltd
-
Australian public assessment report (AusPar)Nextstellis (estetrol monohydrate and drospirenone) for the prevention of pregnancy
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for MAYNE PHARMA ANTIBACTERIAL HAND SANITISER GEL ethanol 80% v/v bottle.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for METARAMINOL MYX metaraminol (as tartrate) 10 mg/1 mL solution for injection ampoule.
-
Prescription medicine decision summaryTGA decision: Nextstellis (estetrol monohydrate and drospirenone) is approved for use by women of reproductive potential to prevent pregnancy.
-
Prescription medicine registrationActive ingredients: estetrol monohydrate; drospirenone.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for ACTIKERALL fluorouracil and salicylic acid 0.5% / 10% (w/w) topical solution, bottle.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for Budesonide Capsules 3mg.